Skip to main content

Table 2 Demographic data of groups according to nutritional status and statistical differences between groups

From: The significance of immunonutrition nutritional support in patients undergoing postoperative adjuvant chemotherapy for lung cancer: case–control study

Variables

Nutritional supplement

Normal diet

p-value

 

No. of patients (n = 46)

Frequency (%)

No. of patients (n = 35)

Frequency (%)

Sex

 Male

42

91.3

26

74.3

0.039

 Female

4

8.7

9

25.7

 

Age

 Mean age of patients (mean ± SD, range) (years) 62 ± 8.2 (48–81)

61.57 ± 10.5 (38–77)

0.689

Comorbidities

 

32

69.6

22

62.9

0.526

Histopathological diagnosis

 Adenocarcinoma

18

39.1

23

65.7

0.018

 Squamous cell carcinoma

28

60.9

12

34.3

 

Histopathological stage

 Stage IIA

2

4.3

4

11.4

0.110

 Stage IIB

23

50

8

51.4

 

 Stage IIIA

15

32.6

13

37.1

 

 Stage IIIB

6

13

-

-

 

Surgical procedures

 Lobar resection

29

63

32

91.4

 

 Pneumonectomy

17

37

3

8.6

0.003

Complications

 

23

50

16

45.7

0.702

Metastasis

    
 

8

17.4

10

28.6

0.231

Mortality

 

11

23.9

13

37.1

0.196

Mean length of hospital stay (LOS) (days)

8.15 ± 0.73 (3–27 ± 5)

8.4 ± 0.87 (3–26 ± 5.14)

0.973